Compassionate use of <scp>long‐acting</scp> cabotegravir plus rilpivirine for people living with <scp>HIV</scp>‐1 in need of parenteral antiretroviral therapyRonald D’Amico, Annemiek de Ruiter, Veerle Van Eygen et al.|HIV Medicine|2022Cited by 46
Rilpivirine as a Treatment for HIV-infected Antiretroviral-naïve AdolescentsJohan Lombaard, Marita Stevens, Torsak Bunupuradah et al.|The Pediatric Infectious Disease Journal|2016Cited by 9
Observational cohort study of rilpivirine (RPV) utilization in EuropeAlessandro Cozzi‐Lepri, Lars N. Nielsen, Lars Peters et al.|AIDS Research and Therapy|2022Cited by 5